The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-month, double-blind, randomi...

por Fraser, David A., Diep, Lien M., Hovden, Inger Anette, Nilsen, Kristian B., Sveen, Kari Anne, Seljeflot, Ingebjørg, Hanssen, Kristian F.
Publicado 2012

Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabe...

por Fraser, David A., Diep, Lien M., Hovden, Inger Anette, Nilsen, Kristian B., Sveen, Kari Anne, Seljeflot, Ingebjørg, Hanssen, Kristian F.
Publicado 2012

Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice

por van den Hoek, Anita M., Pieterman, Elsbet J., van der Hoorn, José W., Iruarrizaga‐Lejarreta, Marta, Alonso, Cristina, Verschuren, Lars, Skjæret, Tore, Princen, Hans M.G., Fraser, David A.
Publicado 2019

A medium-chain fatty acid analogue prevents hepatosteatosis and decreases inflammatory lipid metabolites in a murine model of parenteral nutrition-induced hepatosteatosis

por Cho, Bennet S., Fligor, Scott C., Fell, Gillian L., Secor, Jordan D., Tsikis, Savas T., Pan, Amy, Yu, Lumeng J., Ko, Victoria H., Dao, Duy T., Anez-Bustillos, Lorenzo, Hirsch, Thomas I., Lund, Jenny, Rustan, Arild C., Fraser, David A., Gura, Kathleen M., Puder, Mark
Publicado 2023

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative

por Stokman, Geurt, van den Hoek, Anita M., Denker Thorbekk, Ditte, Pieterman, Elsbet J., Skovgård Veidal, Sanne, Basta, Brittany, Iruarrizaga‐Lejarreta, Marta, van der Hoorn, José W., Verschuren, Lars, Berbée, Jimmy F. P., Rensen, Patrick C. N., Skjæret, Tore, Alonso, Cristina, Feigh, Michael, Kastelein, John J. P., Friedman, Scott L., Princen, Hans M. G., Fraser, David A.
Publicado 2020